Endocrine Abstracts

Background/aim: We aimed to determine the effect of percutaneous ethanol injection (PEI) on volume of cystic and mixt thyroid nodules, thyroid function tests (TFTs), antibody titers and cytological changes for 1 year.Methods: Fifty-five nodules of 53 patients with cystic and mixt properties treated with PEI were included. Nodule volumes, TFTs, thyroid autoantibodies were analyzed at baseline, 6th and 12th months. Fine needle aspirat...

Objective: In primary hiperparathyroidism (PHPT), increasing the number of patients treated by focused parathyroidectomy should be the main objective of pre-surgical imaging modalities. Suspicious or negative imaging results do not always mean multiglandular disease, most of the patients may single adenoma and therefore these patients may still benefit from focused parathyroidectomy.Methods: Retrospectively, we analyzed the data of 65 patients with PHPT ...

Introduction: Accumulating evidence indicate that high PTH resulting from primary or secondary hyperparathyroidism, is associated with hypertension, insulin resistance, dyslipidaemia, obesity, and cardiovascular mortality. Here, we aimed to show whether high PTH levels in obese population contribute the metabolic complications of obesity.Methods/design: The medical records of all subjects attending the obesity outpatient clinic of Kartal Dr Lutfi Kirdar ...

Objective: Elevated levels of the soluble adhesion molecules, sICAM-1 and sVCAM-1 reflect chronic inflammatory state. Increased levels of sICAM-1 and sVCAM-1 were demonstrated in various autoimmune thyroid diseases with abnormal thyroid function, but their clinical significance is undefined, especially in the euthyroid patients with Hashimoto’s thyroiditis (HT). Increased levels of soluble adhesion molecules are also associated with components of the metabolic syndrome li...

Background: Obesity and diabetes mellitus (DM) are the features of Cushing’s disease (CD). Studies indicated different frequencies of CD among obese, type 2 DM patients. The frequency of CD among obese, type 2 DM have’nt been studied in Turkey. Therefore, we aimed to assess the frequency of CD among obese (BMI>30 kg/m2) type 2 DM patients that had not classical morphological findings of CD.Patients and methods: Two hundred consec...

Background: Acromegaly is a multi-systemic dysfiguring disease caused by pituitary GH secreting tumour. Pituitary surgery, medical treatment with somatostatin analogues and radiotherapy have been cornerstone in the management of acromegaly. However, all these treatment modalities do not provide sufficient disease control especially in patients with macroadenomas.Objective: To evaluate the follow-up outcomes and remission rates of acromegaly patients....